1
|
Latz E, Xiao TS and Stutz A: Activation
and regulation of the inflammasomes. Nat Rev Immunol. 13:397–411.
2013.PubMed/NCBI View
Article : Google Scholar
|
2
|
Paik S, Kim JK, Silwal P, Sasakawa C and
Jo EK: An update on the regulatory mechanisms of NLRP3 inflammasome
activation. Cell Mol Immunol. 18:1141–1160. 2021.PubMed/NCBI View Article : Google Scholar
|
3
|
Kaneko N, Kurata M, Yamamoto T, Morikawa S
and Masumoto J: The role of interleukin-1 in general pathology.
Inflamm Regen. 39(12)2019.PubMed/NCBI View Article : Google Scholar
|
4
|
Mangan MSJ, Olhava EJ, Roush WR, Seidel
HM, Glick GD and Latz E: Targeting the NLRP3 inflammasome in
inflammatory diseases. Nat Rev Drug Discov. 17:588–606.
2018.PubMed/NCBI View Article : Google Scholar
|
5
|
Daniels MJD, Rivers-Auty J, Schilling T,
Spencer NG, Watremez W, Fasolino V, Booth SJ, White CS, Baldwin AG,
Freeman S, et al: Fenamate NSAIDs inhibit the NLRP3 inflammasome
and protect against Alzheimer's disease in rodent models. Nat
Commun. 7(12504)2016.PubMed/NCBI View Article : Google Scholar
|
6
|
Dixit VD: Nlrp3 inflammasome activation in
type 2 diabetes: Is it clinically relevant? Diabetes. 62:22–24.
2013.PubMed/NCBI View Article : Google Scholar
|
7
|
Fusco R, Siracusa R, Genovese T, Cuzzocrea
S and Di Paola R: Focus on the role of NLRP3 inflammasome in
diseases. Int J Mol Sci. 21(4223)2020.PubMed/NCBI View Article : Google Scholar
|
8
|
Kanneganti TD: Inflammatory bowel disease
and the NLRP3 inflammasome. N Engl J Med. 377:694–696.
2017.PubMed/NCBI View Article : Google Scholar
|
9
|
Guo C, Fu R, Wang S, Huang Y, Li X, Zhou
M, Zhao J and Yang N: NLRP3 inflammasome activation contributes to
the pathogenesis of rheumatoid arthritis. Clin Exp Immunol.
194:231–243. 2018.PubMed/NCBI View Article : Google Scholar
|
10
|
Sharma D and Kanneganti TD: The cell
biology of inflammasomes: Mechanisms of inflammasome activation and
regulation. J Cell Biol. 213:617–629. 2016.PubMed/NCBI View Article : Google Scholar
|
11
|
Coll RC, Robertson AA, Chae JJ, Higgins
SC, Muñoz-Planillo R, Inserra MC, Vetter I, Dungan LS, Monks BG,
Stutz A, et al: A small-molecule inhibitor of the NLRP3
inflammasome for the treatment of inflammatory diseases. Nat Med.
21:248–255. 2015.PubMed/NCBI View
Article : Google Scholar
|
12
|
Cragg GM and Newman DJ: Nature products: A
contrinuing source of novel drug leads. Biochim Biophys Acta.
1830:3670–3695. 2013.PubMed/NCBI View Article : Google Scholar
|
13
|
Kim AR, Kim HS, Kim DK, Lee JH, Yoo YH,
Kim JY, Park SK, Nam ST, Kim HW, Park YH, et al: The extract of
Chrysanthemum zawadskii var. latilobum ameliorates
collagen-induced arthritis in mice. Evid Based Complement Alternat
Med. 2016(3915013)2016.PubMed/NCBI View Article : Google Scholar
|
14
|
Gu DR, Hwang JK, Erkhembaatar M, Kwon KB,
Kim MS, Lee YR and Lee SH: Inhibitory effect of Chrysanthemum
zawadskii Herbich var. latilobum kitamura extract on
RANKL-induced osteoclast differentiation. Evid Based Complement
Alternat Med. 2013(509482)2013.PubMed/NCBI View Article : Google Scholar
|
15
|
Huang WY, Jeong I, Han BK, Kim MJ, Hong J,
Ahn SII, Heo W, Pan JH, Kim JK, Shin EC and Kim YJ:
Chrysanthemum zawadskii Herbich var. latilobum
(Maxim.) Kitamura water extract prevents BALB/c mice lung injury
from particulate matter 10 toxicity. Food Agric Immunol.
33:252–263. 2022.
|
16
|
Kim Y, Han J, Sung J, Sung M, Choi Y,
Jeong HS and Lee J: Anti-inflammatory activity of Chrysanthemum
zawadskii var. latilobum leaf extract through haem
oxygenase-1 induction. J Funct Foods. 4:474–479. 2012.
|
17
|
Cho BO, Shin JY, Kang HJ, Park JH, Hao S,
Wang F and Jang SI: Anti-inflammatory effect of Chrysanthemum
zawadskii, peppermint, Glycyrrhiza glabra herbal mixture in
lipopolysaccharide-stimulated RAW264.7 macrophages. Mol Med Rep.
24(532)2021.PubMed/NCBI View Article : Google Scholar
|
18
|
Kim KY, Oh TW, Yang HJ, Kim YW, Ma JY and
Park KI: Ethanol extract of Chrysanthemum zawadskii Herbich
induces autophagy and apoptosis in mouse colon cancer cells through
the regulation of reactive oxygen species. BMC Complement Altern
Med. 19(274)2019.PubMed/NCBI View Article : Google Scholar
|
19
|
Celada A, Gray PW, Rinderknecht E and
Schreiber RD: Evidence for a gamma-interferon receptor that
regulates macrophage tumoricidal activity. J Exp Med. 160:55–74.
1984.PubMed/NCBI View Article : Google Scholar
|
20
|
Rao X, Huang X, Zhou Z and Lin X: An
improvement of the 2ˆ(-delta delta CT) method for quantitative
real-time polymerase chain reaction data analysis. Biostat
Bioinforma Biomath. 3:71–85. 2013.PubMed/NCBI
|
21
|
Kelley N, Jeltema D, Duan Y and He Y: The
NLRP3 inflammasome: An overview of mechanisms of activation and
regulation. Int J Mol Sci. 20(3328)2019.PubMed/NCBI View Article : Google Scholar
|
22
|
Bryan NB, Dorfleutner A, Rojanasakul Y and
Stehlik C: Activation of inflammasomes requires intracellular
redistribution of the apoptotic speck-like protein containing a
caspase recruitment domain. J Immunol. 182:3173–3182.
2009.PubMed/NCBI View Article : Google Scholar
|
23
|
Hara H, Tsuchiya K, Kawamura I, Fang R,
Hernandez-Cuellar E, Shen Y, Mizuguchi J, Schweighoffer E,
Tybulewicz V and Mitsuyama M: Phosphorylation of the adaptor ASC
acts as a molecular switch that controls the formation of
speck-like aggregates and inflammasome activity. Nat Immunol.
14:1247–1255. 2013.PubMed/NCBI View Article : Google Scholar
|
24
|
Zheng D, Liwinski T and Elinav E:
Inflammasome activation and regulation: Toward a better
understanding of complex mechanisms. Cell Discov.
6(36)2020.PubMed/NCBI View Article : Google Scholar
|
25
|
Hong S, Joo T and Jhoo JW: Antioxidant and
anti-inflammatory activities of 3,5-dicaffeoylquinic acid isolated
from Ligularia fischeri leaves. Food Sci Biotechnol. 24:257–263.
2015.
|
26
|
Hwang SJ, Kim YW, Park Y, Lee HJ and Kim
KW: Anti-inflammatory effects of chlorogenic acid in
lipopolysaccharide-stimulated RAW 264.7 cells. Inflamm Res.
63:81–90. 2014.PubMed/NCBI View Article : Google Scholar
|
27
|
Kim B, Lee JH, Seo MJ, Eom SH and Kim W:
Linarin down-regulates phagocytosis, pro-inflammatory cytokine
production, and activation marker expression in RAW264.7
macrophages. Food Sci Biotechnol. 25:1437–1442. 2016.PubMed/NCBI View Article : Google Scholar
|
28
|
Tőzsér J and Benkő S: Natural compounds as
regulators of NLRP3 inflammasome-mediated IL-1β production.
Mediators Inflamm. 2016(5460302)2016.PubMed/NCBI View Article : Google Scholar
|
29
|
Kim B and Kim HS: Chrysanthemum
zawadskii extract activates peroxisome proliferator-activated
receptor-α and has an anti-inflammatory activity: Potential
interest for the skin barrier function. Korean J Chem Eng.
31:1831–1838. 2014.
|
30
|
Yu SH, Sun X, Kim MK, Akther M, Han JH,
Kim TY, Jiang J, Kang TB and Lee KH: Chrysanthemum indicum
extract inhibits NLRP3 and AIM2 inflammasome activation via
regulating ASC phosphorylation. J Ethnopharmacol.
239(111917)2019.PubMed/NCBI View Article : Google Scholar
|
31
|
Lou L, Zhou J, Liu Y, Wei YI, Zhao J, Deng
J, Dong B, Zhu L, Wu A, Yang Y and Chai L: Chlorogenic acid induces
apoptosis to inhibit inflammatory proliferation of IL-6-induced
fibroblast-like synoviocytes through modulating the activation of
JAK/STAT and NF-κB signaling pathways. Exp Ther Med. 11:2054–2060.
2016.PubMed/NCBI View Article : Google Scholar
|
32
|
Shi A, Shi H, Wang Y, Liu X, Cheng Y, Li
H, Zhao H, Wang S and Dong L: Activation of Nrf2 pathway and
inhibition of NLRP3 inflammasome activation contribute to the
protective effect of chlorogenic acid on acute liver injury. Int
Immunopharmacol. 54:125–130. 2018.PubMed/NCBI View Article : Google Scholar
|
33
|
Han X, Wu YC, Meng M, Sun QS, Gao SM and
Sun H: Linarin prevents LPS-induced acute lung injury by
suppressing oxidative stress and inflammation via inhibition of
TXNIP/NLRP3 and NF-κB pathways. Int J Mol Med. 42:1460–1472.
2018.PubMed/NCBI View Article : Google Scholar
|
34
|
Kwak SB, Koppula S, In EJ, Sun X, Kim YK,
Kim MK, Lee KH and Kang TB: Artemisia extract suppresses NLRP3 and
AIM2 inflammasome activation by inhibition of ASC phosphorylation.
Mediators Inflamm. 2018(6054069)2018.PubMed/NCBI View Article : Google Scholar
|
35
|
Yang Y, Wang H, Kouadir M, Song H and Shi
F: Recent advances in the mechanisms of NLRP3 inflammasome
activation and its inhibitors. Cell Death Dis.
10(128)2019.PubMed/NCBI View Article : Google Scholar
|
36
|
Qu Y, Misaghi S, Newton K, Maltzman A,
Izrael-Tomasevic A, Arnott D and Dixit VM: NLRP3 recruitment by
NLRC4 during Salmonella infection. J Exp Med. 213:877–885.
2016.PubMed/NCBI View Article : Google Scholar
|
37
|
Jiang Y, Lin Y, Hu YJ, Song XJ, Pan HH and
Zhang HJ: Caffeoylquinic acid derivatives rich extract from
Gnaphalium pensylvanicum willd. Ameliorates hyperuricemia
and acute gouty arthritis in animal model. BMC Complement Altern
Med. 17(320)2017.PubMed/NCBI View Article : Google Scholar
|